James L Tyree - Net Worth and Insider Trading

James L Tyree Net Worth

The estimated net worth of James L Tyree is at least $16 Million dollars as of 2024-04-26. James L Tyree is the Executive Vice President of Abbott Laboratories and owns about 132,176 shares of Abbott Laboratories (ABT) stock worth over $14 Million. James L Tyree is the Director of ChemoCentryx Inc and owns about 19,138 shares of ChemoCentryx Inc (CCXI) stock worth over $994,985. James L Tyree is also the Director of Innoviva Inc and owns about 50,697 shares of Innoviva Inc (INVA) stock worth over $759,948. Besides these, James L Tyree also holds Assertio Holdings Inc (ASRT) , Genelux Corp (GNLX) . Details can be seen in James L Tyree's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James L Tyree has not made any transactions after 2024-03-14 and currently still holds the listed stock(s).

Transaction Summary of James L Tyree

To

James L Tyree Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James L Tyree owns 5 companies in total, including ChemoCentryx Inc (CCXI) , Assertio Holdings Inc (ASRT) , and Innoviva Inc (INVA) among others .

Click here to see the complete history of James L Tyree’s form 4 insider trades.

Insider Ownership Summary of James L Tyree

Ticker Comapny Transaction Date Type of Owner
CCXI ChemoCentryx Inc 2022-06-09 director
ASRT Assertio Holdings Inc 2024-03-14 director
INVA Innoviva Inc 2016-05-18 director
ABT Abbott Laboratories 2009-02-27 Senior Vice President
GNLX Genelux Corp 2023-12-13 director

James L Tyree Latest Holdings Summary

James L Tyree currently owns a total of 5 stocks. Among these stocks, James L Tyree owns 132,176 shares of Abbott Laboratories (ABT) as of February 27, 2009, with a value of $14 Million and a weighting of 88.06%. James L Tyree owns 19,138 shares of ChemoCentryx Inc (CCXI) as of June 9, 2022, with a value of $994,985 and a weighting of 6.2%. James L Tyree also owns 50,697 shares of Innoviva Inc (INVA) as of May 18, 2016, with a value of $759,948 and a weighting of 4.74%. The other 2 stocks Assertio Holdings Inc (ASRT) , Genelux Corp (GNLX) have a combined weighting of 0.99% among all his current holdings.

Latest Holdings of James L Tyree

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABT Abbott Laboratories 2009-02-27 132,176 106.86 14,124,327
CCXI ChemoCentryx Inc 2022-06-09 19,138 51.99 994,985
INVA Innoviva Inc 2016-05-18 50,697 14.99 759,948
ASRT Assertio Holdings Inc 2024-03-14 188,251 0.79 147,796
GNLX Genelux Corp 2023-12-13 3,460 3.32 11,487

Holding Weightings of James L Tyree


James L Tyree Form 4 Trading Tracker

According to the SEC Form 4 filings, James L Tyree has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 10,454 shares on February 27, 2009, which brought James L Tyree around $498,447.

According to the SEC Form 4 filings, James L Tyree has made a total of 4 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in ChemoCentryx Inc is the sale of 3,863 shares on June 9, 2022, which brought James L Tyree around $99,125.

According to the SEC Form 4 filings, James L Tyree has made a total of 0 transactions in Innoviva Inc (INVA) over the past 5 years. The most-recent trade in Innoviva Inc is the sale of 813 shares on May 18, 2016, which brought James L Tyree around $8,512.

More details on James L Tyree's insider transactions can be found in the Insider Trading History of James L Tyree table.

Insider Trading History of James L Tyree

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James L Tyree Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James L Tyree Ownership Network

Ownership Network List of James L Tyree

No Data

Ownership Network Relation of James L Tyree


James L Tyree Owned Company Details

What does ChemoCentryx Inc do?

Who are the key executives at ChemoCentryx Inc?

James L Tyree is the director of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , director & 10 percent owner & President & CEO and Director Thomas J. Schall , and SVP & Finance & Acctg Officer Yi Ching Yau .

ChemoCentryx Inc (CCXI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ChemoCentryx Inc Insider Transactions

No Available Data

James L Tyree Mailing Address

Above is the net worth, insider trading, and ownership report for James L Tyree. You might contact James L Tyree via mailing address: 100 Abbott Park Road, Abbott Park Il 60064-6400.

Discussions on James L Tyree

No discussions yet.